93 related articles for article (PubMed ID: 12540747)
1. K+ channel structure-activity relationships and mechanisms of drug-induced QT prolongation.
Clancy CE; Kurokawa J; Tateyama M; Wehrens XH; Kass RS
Annu Rev Pharmacol Toxicol; 2003; 43():441-61. PubMed ID: 12540747
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of potassium channel blockade and drug-induced arrhythmias.
Wehrens XH
Handb Exp Pharmacol; 2006; (171):123-57. PubMed ID: 16610343
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of high-affinity drug binding to HERG channels.
Mitcheson JS; Perry MD
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):667-74. PubMed ID: 14579516
[TBL] [Abstract][Full Text] [Related]
4. Predicting drug-hERG channel interactions that cause acquired long QT syndrome.
Sanguinetti MC; Mitcheson JS
Trends Pharmacol Sci; 2005 Mar; 26(3):119-24. PubMed ID: 15749156
[TBL] [Abstract][Full Text] [Related]
5. QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
Recanatini M; Poluzzi E; Masetti M; Cavalli A; De Ponti F
Med Res Rev; 2005 Mar; 25(2):133-66. PubMed ID: 15389727
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
8. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
Calderone V; Cavero I
Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
[TBL] [Abstract][Full Text] [Related]
9. Cardiac K+ channels and drug-acquired long QT syndrome.
Drici MD; Barhanin J
Therapie; 2000; 55(1):185-93. PubMed ID: 10860023
[TBL] [Abstract][Full Text] [Related]
10. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
12. Do all antidepressants cause QT prolongation--how good is the evidence?
Glue P; Gale C
N Z Med J; 2013 Feb; 126(1369):90-1. PubMed ID: 23463117
[No Abstract] [Full Text] [Related]
13. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
Kecskeméti V
Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in the proarrhythmic potential of QT-prolonging drugs.
Wolbrette D
Curr Womens Health Rep; 2002 Apr; 2(2):105-9. PubMed ID: 12116598
[TBL] [Abstract][Full Text] [Related]
15. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
16. [Preclinical evaluation of drug induced QT prolongation].
Hashimoto K
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):408-10. PubMed ID: 12899128
[No Abstract] [Full Text] [Related]
17. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
Takahara A; Sugiyama A; Hashimoto K
Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
[TBL] [Abstract][Full Text] [Related]
18. The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment.
Fossa AA; DePasquale MJ; Raunig DL; Avery MJ; Leishman DJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):828-33. PubMed ID: 12130750
[TBL] [Abstract][Full Text] [Related]
19. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
[TBL] [Abstract][Full Text] [Related]
20. Effects of K openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs.
Testai L; Cecchetti V; Sabatini S; Martelli A; Breschi MC; Calderone V
J Pharm Pharmacol; 2010 Jul; 62(7):924-30. PubMed ID: 20636881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
